News & Updates
Filter by Specialty:
Thrombocytopaenia, platelet dysfunction common in Parkinson’s disease
Despite having no such history, about a third of patients with Parkinson’s disease (PD) show evidence of thrombocytopaenia or platelet dysfunction, reports a recent study.
Thrombocytopaenia, platelet dysfunction common in Parkinson’s disease
10 Sep 2022
CROWN: 1L lorlatinib improves PFS, reduces CNS progression in ALK-positive NSCLC ± brain metastases
First-line treatment of ALK-positive non-small-cell lung cancer (NSCLC) with lorlatinib improves progression-free survival (PFS) and reduces central nervous system (CNS) progression vs crizotinib, regardless of presence or absence of baseline brain metastases (BM), a post hoc analysis of the phase III CROWN trial has shown.
CROWN: 1L lorlatinib improves PFS, reduces CNS progression in ALK-positive NSCLC ± brain metastases
09 Sep 2022
Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
A post hoc analysis of the SUSTAIN 6 and PIONEER 6 trials has found that semaglutide reduces incidence of any stroke in people with type 2 diabetes (T2D) at high cardiovascular (CV) risk vs placebo.
Semaglutide lowers stroke risk in type 2 diabetes with high CV risk
09 Sep 2022
Shift work carries higher cardiometabolic multimorbidity risk in hypertension
Hypertensive patients who work shifts face an increased risk of developing more than two cardiometabolic diseases or cardiometabolic multimorbidity, according to a study.
Shift work carries higher cardiometabolic multimorbidity risk in hypertension
08 Sep 2022
Hypertensive disorders of pregnancy: A risk factor for dementia?
Individuals with a history of hypertensive disorders of pregnancy (HDP) appear to have an increased risk of developing dementia, particularly vascular dementia, according to a study presented at AAIC 2022.